Outlook Therapeutics
Patents, Design & Utilities
Last updated:
List of all Outlook Therapeutics patents 3 in total
| Status | Patent |
|---|---|
Application | Utility: BUFFERED FORMULATIONS OF BEVACIZUMAB FOR USE OF TREATING DISEASES Filling date: 26 Sep 2025 Issue date: 29 Jul 2021 |
Grant | Utility: Modulation of charge variants in a monoclonal antibody composition Filling date: 26 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Buffer formulations for enhanced antibody stability Filling date: 26 Sep 2025 Issue date: 13 Aug 2019 |
Showing 1 to 3 of 3 patents.